180 likes | 209 Views
Learn about the current situation, challenges, achievements, and future plans for cervical cancer prevention and treatment in Kenya. Discover how DRH is leading policy development, coordination, and monitoring in collaboration with stakeholders.
E N D
Scaling up cervical cancer prevention and treatment in Kenya DR Nakato Jumba DRH CERVICAL CANCER PARTNER FORUM, ELDORET 10TH AUGUST 2012
Outline DRH mandate Background / Introduction Current situation Country plans Achievements Challenges
DRH mandate Policy formulation and development Coordination of stakeholders Development of guidelines Monitoring and evaluation DRH and Cervical Cancer DRH is the secretariat for the National CECAP program CECAP housed under the RT Cancer Program
Background /Introduction Cervical cancer is the second most common cancer in Kenya Its the most common cause of cancer related deaths in Kenya Oncogenic HPV prevalence in general population is high- 60.9% Most clients present late in the disease ( Stage 3 and above) Extremely high case fatality rate
Total population (2009): 38.6 million Women at Risk for CA Cx ( >15 yrs): 10.6 million Annual no of cervical cancer cases: 2454 Annual number of cervical cancer deaths: 1676 Projected new Cervical cancer cases 2025: 4261 Screening coverage women 18 -69 yrs- 3.2% Kenya Situation analysis Equator NAIROBI Kenya Census report 2009; Globocan – IARC , 2008
Challenges - 1 • Asymptomatic until advanced- This hampers visibility and advocacy efforts • Primarily affects women – success of interventions limited due to gender imbalances, cultural practices, women’s empowerment etc • Health systems – poor infrastructure, poor road transport and communication, inadequate commodities, supplies and equipment; limited availability of diagnosis and treatment for overt cancers
Challenges -2 • Financing – minimal financial support for CECAP • Human Resources- numbers, distribution, competencies • HMIS- poor data management systems • Governance: Two Ministries of Health; Low prioritisation in health agenda
Achievements National strategy, guidelines, M&E tools have been developed Quarterly RT cancer TWG meetings National TOTs developed M&E system being rolled out and key indicators to be incorporated into DHIS Regular supportive supervision being implemented Equipment for Dysplasia treatment being procured Advocacy being scaled up
Achievements -2 • Awareness at ministerial level • Several parliamentary papers have been presented • CECAP on of the 3 main areas of focus for DFH in AOP 7 • CECAP included as budget line item in national budget fy 2011/2012 • HPV introduction planning meetings in process
Achievements -3Systems strengthening • Procurement of cryotherapy equipment – • National budget – 75 • Jhpiego-50+ • GF rd 10 – 50 • Pathfinder- 30+ • CDC / ICAP- • Capacity strengthening • TOTs • Service provider trainings
Resource mobilisation Slowly realising more investment in CECAP • GOK • USAID • CDC • Global fund • BMF- under Tupange project • Exploring NHIF to include in minimum service package
Achievements -4Service Delivery • Integration in routine service delivery • Integration into outreach services • Integration into HIV/ AIDS services • Integration into world health days
Next Steps • Scale up Advocacy and awareness creation • Scale up Service provider trainings • Procurement of additional treatment equipment • Increase service coverage to all level 3 facilities and above • Finalize and disseminate sector documents • Application for HPV vaccine for girls 9- 13 years • Scale up resource mobilization strategies • Scale up operations research
Conclusion • Let us strengthen partnerships to reposition and scale up cervical cancer prevention and control